Skip to main content
SpringerLink
Log in

Paraneoplastische seröse Retinopathien: Hormone, Mediatoren und Inhibitoren

Paraneoplastic serous retinopathies: hormones, mediators, and inhibitors

  • Leserbriefe
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

The Original Article was published on 12 February 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ludeke I, Terheyden P, Grisanti S, Luke M (2016) Development of serous retinopathy during therapy of a metastatic cutaneous melanoma. Ophthalmologe 113:861–863. doi:10.1007/s00347-016-0226-8

    Article  CAS  PubMed  Google Scholar 

  2. Grajewski RS, Schuler-Thurner B, Mauch C, Kreuzberg N, Koch KR, Bergua A, Cursiefen C, Heindl LM (2014) Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers. Graefes Arch Clin Exp Ophthalmol 252:679–685. doi:10.1007/s00417-013-2563-5

    Article  PubMed  Google Scholar 

  3. Grunwald L, Kligman BE, Shields CL (2011) Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma. Arch Ophthalmol 129:1104–1106. doi:10.1001/archophthalmol.2011.215

    Article  PubMed  Google Scholar 

  4. Modi KK, Roth DB, Green SN (2014) Acute exudative polymorphous vitelliform maculopathy in a young man: a case report. Retin Cases Brief Rep 8:200–204. doi:10.1097/ICB.0000000000000042

    Article  PubMed  Google Scholar 

  5. Symeonidis C, Kaprinis K, Manthos K, Androudi S, Anastassilakis K, Dimitrakos SA (2011) Central serous chorioretinopathy with subretinal deposition of fibrin-like material and its prompt response to ranibizumab injections. Case Rep Ophthalmol 2(1):59–64. doi:10.1159/000324701

    PubMed  PubMed Central  Google Scholar 

  6. Carey RM, Orth DN, Hartmann WH (1973) Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab 36:482–487. doi:10.1210/jcem-36-3-482

    Article  CAS  PubMed  Google Scholar 

  7. Klaassen I, Van Noorden CJ, Schlingemann RO (2013) Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 34:19–48. doi:10.1016/j.preteyeres.2013.02.001

    Article  CAS  PubMed  Google Scholar 

  8. Duncan KE, Chang LY, Patronas M (2015) MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity. Eye (Lond) 29:1003–1012. doi:10.1038/eye.2015.82

    Article  CAS  Google Scholar 

  9. McCannel TA, Chmielowski B, Finn RS, Goldman J, Ribas A, Wainberg ZA, McCannel CA (2014) Bilateral subfoveal neurosensory retinal detachment associated with MEK inhibitor use for metastatic cancer. JAMA Ophthalmol 132:1005–1009. doi:10.1001/jamaophthalmol.2014.976

    Article  PubMed  Google Scholar 

  10. Weber ML, Liang MC, Flaherty KT, Heier JS (2016) Subretinal fluid associated with MEK inhibitor use in the treatment of systemic cancer. JAMA Ophthalmol 134:855–862. doi:10.1001/jamaophthalmol.2016.0090

    Article  PubMed  Google Scholar 

Download references

Förderung

Deutsche Forschungsgemeinschaft: Forschergruppe: FOR 2240 „(Lymph) Angiogenesis And Cellular Immunity In Inflammatory Diseases Of The Eye“ (an RSG und LMH; GR 2647/5-1 an RSG; HE 6743/2-1 und 3‑1 an LMH)

Author information

Authors and Affiliations

  1. Zentrum für Augenheilkunde, Universität zu Köln, Kerpener Str. 62, 50924, Köln, Deutschland

    R. S. Grajewski & L. M. Heindl

Authors
  1. R. S. Grajewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Heindl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. S. Grajewski.

Ethics declarations

Interessenkonflikt

R.S. Grajewski und L.M. Heindl geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grajewski, R.S., Heindl, L.M. Paraneoplastische seröse Retinopathien: Hormone, Mediatoren und Inhibitoren. Ophthalmologe 114, 377–378 (2017). https://doi.org/10.1007/s00347-017-0459-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-017-0459-1

Search

Navigation